Hyperbaric oxygen therapy may improve symptoms in autistic children

Medical Hypotheses

Volumn 67, Issue 2, 2006, Pages 216-228

  Rossignol, Daniel A ^a,b   Rossignol, Lanier W ^c  

^a Blue Ridge Medical Center   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD FLOW; BONE MARROW CELL; CEREBRAL PALSY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FETAL ALCOHOL SYNDROME; HEAD INJURY; HEARING; HUMAN; HYPERBARIC OXYGEN; INFANTILE AUTISM; LANGUAGE; MEDICAL RESEARCH; OXIDATIVE STRESS; PERFUSION; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEM CELL MOBILIZATION; STEREOTYPY; STROKE; UNITED STATES;

AUTISTIC DISORDER; CELL MOVEMENT; CEREBRAL CORTEX; CHILD; HUMANS; HYPERBARIC OXYGENATION; OXIDATIVE STRESS; STEM CELLS; TREATMENT OUTCOME;

ANIMALIA;

EID: 33744739160     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.02.009     Document Type: Article

References (133)

1. Singh N (contact). Press release: CDC launches "Learn the signs. Act early." Campaign, http://www.cdc.gov/od/oc/media/pressrel/r050222.htm; February 22, 2005 [accessed 21.01.06].
2. Kanner L. Autistic disturbances of affective contact. Nervous Child 2 (1943) 217-250
3. Rapin I. Autism. N Engl J Med 337 2 (1997) 97-104
4. Wing L., and Potter D. The epidemiology of autistic spectrum disorders: is the prevalence rising?. Ment Retard Dev Disabil Res Rev 8 3 (2002) 151-161
5. Stokstad E. New hints into the biological basis of autism. Science 294 (2001) 34-37
6. Muhle R., Trentacoste S.V., and Rapin I. The genetics of autism. Pediatrics 113 (2004) 472-486
7. Centers for Disease Control and Prevention. How common is autism spectrum disorder? www.cdc.gov/ncbddd/autism/asd_common.htm; February 17, 2005 [accessed 21.01.06].
8. Gillberg C., and Wing L. Autism: not an extremely rare disorder. Acta Psychiatr Scand 99 6 (1999) 399-406
9. Feldmeier JJ. Chairman and Editor. Hyperbaric oxygen 2003: indications and results: the hyperbaric oxygen therapy committee report. Kensington, MD: Undersea and Hyperbaric Medical Society; 2003.
10. Leach R.M., Rees P.J., and Wilmshurst P. ABC of oxygen: hyperbaric oxygen therapy. BMJ 317 (1998) 1140-1143
11. Steele J., Matos L.A., Lopez E.A., et al. A phase 1 safety study of hyperbaric oxygen therapy for amyotrophic lateral sclerosis. ALS 5 (2004) 250-254
12. Kiralp M.Z., Yildiz S., Vural D., Keskin I., Ay H., and Dursun H. Effectiveness of hyperbaric oxygen therapy in the treatment of complex regional pain syndrome. J Int Med Res 32 (2004) 258-262
13. Stoller K.P. Quantification of neurocognitive changes before, during, and after hyperbaric oxygen therapy in a case of fetal alcohol syndrome. Pediatrics 116 (2005) 586-591
14. Neubauer R.A., Gottlieb S.F., and Miale A. Identification of hypometabolic areas in the brain using brain imaging and hyperbaric oxygen. Clin Nucl Med 17 6 (1992) 477-481
15. Rockswold G.L., Ford S.E., Anderson D.C., Bergman T.A., and Sherman R.E. Results of a prospective randomized trial for the treatment of severely brain-injured patients with hyperbaric oxygen. J Neurosurg 76 6 (1992) 929-934
16. Shandling A.H., Ellestad M.H., Hart G.B., et al. Hyperbaric oxygen and thrombolysis in myocardial infarction: the "HOT MI" pilot study. Am Heart J 134 (1997) 544-550
17. Gill A.L., and Bell C.A.N. Hyperbaric oxygen: its uses, mechanisms of action and outcomes. Q J Med 97 (2004) 385-395
18. Ackerman N.B., and Brinkley F.B. Oxygen tensions in normal and ischemic tissues during hyperbaric therapy. JAMA 198 12 (1966) 1280-1283
19. Calvert J.W., Yin W., Patel M., et al. Hyperbaric oxygenation prevented brain injury induced by hypoxia-ischemia in a neonatal rat model. Brain Res 951 (2002) 1-8
20. Sukoff M.H., and Ragatz R.E. Hyperbaric oxygenation for the treatment of acute cerebral edema. Neurosurgery 10 1 (1982) 29-38
21. Bird A.D., and Telfer A.B. Effect of hyperbaric oxygen on limb circulation. Lancet 13 (1965) 355-356
22. Nylander G., Lewis D., Nordstrom H., and Larsson J. Reduction of postischemic edema with hyperbaric oxygen. Plast Reconstr Surg 76 4 (1985) 596-603
23. Veltkamp R., Siebing D.A., Sun L., et al. Hyperbaric oxygen reduces blood-brain barrier damage and edema after transient focal cerebral ischemia. Stroke 36 (2005) 1679-1683
24. Nuthall G., Seear M., Lepawsky M., Wensley D., Skippen P., and Hukin J. Hyperbaric oxygen therapy for cerebral palsy: two complications of treatment. Pediatrics 106 6 (2000) E80
25. Ashamalla H.L., Thom S.R., and Goldwein J.W. Hyperbaric oxygen therapy for the treatment of radiation-induced sequelae in children: the University of Pennsylvania experience. Cancer 77 11 (1996) 2407-2412
26. Ryu Y.H., Lee J.D., Yoon P.H., Kim D.I., Lee H.B., and Shin Y.J. Perfusion impairments in infantile autism on technetium-99m ethyl cysteinate dimer brain single-photon emission tomography: comparison with findings on magnetic resonance imaging. Eur J Nucl Med 26 3 (1999) 253-259
27. Wilcox J., Tsuang M.T., Ledger E., Algeo J., and Schnurr T. Brain perfusion in autism varies with age. Neuropsychobiology 46 (2002) 13-16
28. Chiron C., Leboyer M., Leon F., Jambaque I., Nuttin C., and Syrota A. SPECT of the brain in childhood autism: evidence for a lack of normal hemispheric asymmetry. Dev Med Child Neurol 37 10 (1995) 849-860
29. Starkstein S.E., Vazquez S., Vrancic D., et al. SPECT findings in mentally retarded autistic individuals. J Neuropsychiatry Clin Neurosci 12 (2000) 370-375
30. Mountz J.M., Tolbert L.C., Lill D.W., Katholi C.R., and Liu H.G. Functional deficits in autistic disorder: characterization by technetium-99m-HMPAO and SPECT. J Nucl Med 36 7 (1995) 1156-1162
31. Ohnishi T., Matsuda H., Hashimoto T., et al. Abnormal regional cerebral blood flow in childhood autism. Brain 123 (2000) 1838-1844
32. George M.S., Costa D.C., Kouris K., Ring H.A., and Ell P.J. Cerebral blood flow abnormalities in adults with infantile autism. J Nerv Ment Dis 180 7 (1992) 413-417
33. Boddaert N., and Zilbovicius M. Functional neuroimaging and childhood autism. Pediatr Radiol 32 (2002) 1-7
34. Zilbovicius M., Boddaert N., Belin P., et al. Temporal lobe dysfunction in childhood autism: a PET study. Am J Psychiatry 157 (2000) 1988-1993
35. Kaya M., Karasalihoglu S., Ustun F., et al. The relationship between 99mTc-HMPAO brain SPECT and the scores of real life rating scale in autistic children. Brain Dev 24 (2002) 77-81
36. Hashimoto T., Sasaki M., Fukumizu M., Hanaoka S., Sugai K., and Matsuda H. Single-photon emission computed tomography of the brain in autism: effect of the developmental level. Pediatr Neurol 23 (2000) 416-420
37. Gillberg I.C., Bjure J., Uvebrant P., Vestergren E., and Gillberg C. SPECT (single photon emission computed tomography) in 31 children and adolescents with autism and autism-like conditions. Eur Child Adolesc Psychiatry 2 1 (1993) 50-59
38. Boddaert N., Belin P., Chabane N., et al. Perception of complex sounds: abnormal pattern of cortical activation in autism. Am J Psychiatry 160 (2003) 2057-2060
39. Boddaert N., Chabane N., Belin P., et al. Perception of complex sounds in autism: abnormal auditory cortical processing in children. Am J Psychiatry 161 (2004) 2117-2120
40. Ichiyama T., Nishikawa M., Hayashi T., Koga M., Tashiro N., and Furukawa S. Cerebral hypoperfusion during acute Kawasaki disease. Stroke 29 (1998) 1320-1321
41. Zilbovicius M., Garreau B., Samson Y., et al. Delayed maturation of the frontal cortex in childhood autism. Am J Psychiatry 152 2 (1995) 248-252
42. Critchley H.D., Daly E.M., Bullmore E.T., et al. The functional neuroanatomy of social behaviour: changes in cerebral blood flow when people with autistic disorder process facial expressions. Brain 123 (2000) 2203-2212
43. Fox P.T., and Raichle M.E. Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects. Proc Natl Acad Sci USA 83 (1986) 1140-1144
44. Parri R., and Crunelli V. An astrocyte bridge from synapse to blood flow. Nat Neurosci 6 1 (2003) 5-6
45. Bruneau N., Dourneau M.C., Garreau B., Pourcelot L., and Lelord G. Blood flow response to auditory stimulations in normal, mentally retarded, and autistic children: a preliminary transcranial Doppler ultrasonographic study of the middle cerebral arteries. Biol Psychiatry 32 (1992) 691-699
46. Mulligan S.J., and MacVicar B.A. Calcium transients in astrocyte endfeet cause cerebrovascular constrictions. Nature 431 (2004) 195-199
47. Zonta M., Angulo M.C., Gobbo S., et al. Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat Neurosci 6 1 (2003) 43-50
48. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 5 (2004) 347-360
49. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., and Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57 (2005) 67-81
50. Huang W.S., Chiu P.Y., Tsai C.H., Kao A., and Lee C.C. Objective evidence of abnormal regional cerebral blood flow in patients with systemic lupus erythematosus on Tc-99m ECD brain SPECT. Rheumatol Int 22 (2002) 178-181
51. Postiglione A., De Chiara S., Soricelli A., et al. Alterations of cerebral blood flow and antiphospholipid antibodies in patients with systemic lupus erythematosus. Int J Clin Lab Res 28 (1998) 34-38
52. Lass P., Krajka-Lauer J., Homziuk M., et al. Cerebral blood flow in Sjögren's syndrome using 99Tcm-HMPAO brain SPET. Nucl Med Commun 21 (2001) 31-35
53. Caca I., Nazaroglu H., Unlu K., Cakmak S.S., Ari S., and Sakalar Y.B. Color Doppler imaging of ocular hemodynamic changes in Behçet's disease. Jpn J Ophthalmol 48 (2004) 101-105
54. Wakamoto H., Ohta M., Nakano N., and Kunisue K. SPECT in focal enterovirus encephalitis: evidence for local cerebral vasculitis. Pediatr Neurol 23 (2000) 429-431
55. Nishikawa M., Matsubara T., Yoshitomi T., Ichiyama T., Hayashi T., and Furukawa S. Abnormalities of brain perfusion in echovirus type 30 meningitis. J Neurol Sci 179 (2000) 122-126
56. Mathieu A., Sanna G., Mameli A., et al. Sustained normalization of cerebral blood-flow after iloprost therapy in a patient with neuropsychiatric systemic lupus erythematosus. Lupus 11 (2002) 52-56
57. Liu F.Y., Huang W.S., Kao C.H., Yen R.F., Wang J.J., and Ho S.T. Usefulness of Tc-99m ECD brain SPECT to evaluate the effects of methylprednisolone pulse therapy in lupus erythematosus with brain involvement: a preliminary report. Rheumatol Int 23 (2003) 182-185
58. Pierce K., Haist F., Sedaghat F., and Courchesne E. The brain response to personally familiar faces in autism: findings of fusiform activity and beyond. Brain 127 (2004) 2703-2716
59. Bachevalier J. Medial temporal lobe structures and autism: a review of clinical and experimental findings. Neuropsychologia 32 6 (1994) 627-648
60. Bolton P.F., and Griffiths P.D. Association of tuberous sclerosis of temporal lobes with autism and atypical autism. Lancet 349 (1997) 392-395
61. Chugani H.T., Da Silva E., and Chugani D.C. Infantile spasms. III. Prognostic implications of bitemporal hypometabolism on positron emission tomography. Ann Neurol 39 5 (1996) 643-649
62. Gillberg C. Brief report: onset of age 14 of a typical autistic syndrome. A case report of a girl with herpes simplex encephalitis. J Autism Dev Disord 16 3 (1986) 369-375
63. Ghaziuddin M., Tsai L.Y., Eilers L., and Ghaziuddin N. Brief report: autism and herpes simplex encephalitis. J Autism Dev Disord 22 1 (1992) 107-113
64. DeLong G.R., Bean S.C., and Brown F.R. Acquired reversible autistic syndrome in acute encephalopathic illness in children. Arch Neurol 38 3 (1981) 191-194
65. Neubauer R.A., and James P. Cerebral oxygenation and the recoverable brain. Neurol Res 20 Suppl. 1 (1998) S33-S36
66. Sheffield P.J., and Davis J.C. Application of hyperbaric oxygen therapy in a case of prolonged cerebral hypoxia following rapid decompression. Aviat Space Environ Med 47 7 (1976) 759-762
67. Astrup J., Symon L., and Siesjo B.K. Thresholds in cerebral ischemia-the ischemic penumbra. Stroke 12 6 (1981) 723-725
68. Neubauer R.A., Gottlieb S.F., and Kagan R.L. Enhancing "idling" neurons. Lancet 335 8688 (1990) 542
69. Olsen T.S., Larsen B., Herning M., Skriver E.B., and Lassen N.A. Blood flow and vascular reactivity in collaterally perfused brain tissue. Evidence of an ischemic penumbra in patients with acute stroke. Stroke 14 3 (1983) 332-341
70. Jacobson I., Harper A.M., and McDowall D.G. The effects of oxygen under pressure on cerebral blood-flow and cerebral venous oxygen tension. Lancet 18 (1963) 549
71. Kapp J.P., Phillips M., Markov A., and Smith R.R. Hyperbaric oxygen after circulatory arrest: modification of postischemic encephalopathy. Neurosurgery 11 4 (1982) 496-499
72. Wallace D.J., Silverman S., Goldstein J., and Hughes D. Use of hyperbaric oxygen in rheumatic diseases: case report and critical analysis. Lupus 5 1 (1996) 84
73. Holbach K.H., Wassmann H., and Kolberg T. Improved reversibility of the traumatic midbrain syndrome using hyperbaric oxygen. Acta Neurochir (Wien) 30 3-4 (1974) 247-256
74. Nighoghossian N., Trouillas P., Adeleine P., and Salord F. Hyperbaric oxygen in the treatment of acute ischemic stroke. Stroke 26 (1995) 1369-1372
75. Kao C.H., Wang S.J., and Yeh S.H. The relationship among the quantitative perfusion-defect indices in Tc-99m HMPAO brain SPECT, IQ test, and involved extremities in children with cerebral palsy due to perinatal asphyxia. Clin Nucl Med 19 4 (1994) 309-313
76. Montgomery D., Goldberg J., Amar M., et al. Effects of hyperbaric oxygen therapy on children with spastic diplegic cerebral palsy: a pilot project. Undersea Hyperb Med 26 4 (1999) 235-242
77. Riikonen R., Salonen I., Partanen K., and Verho S. Brain perfusion SPECT and MRI in foetal alcohol syndrome. Dev Med Child Neurol 41 (1999) 652-659
78. Heuser G., Heuser S.A., Rodelander D., Aguilera O., and Uszler M. Treatment of neurologically impaired adults and children with "mild" hyperbaric oxygenation (1.3 ATA and 24% oxygen). In: Joiner J.T. (Ed). Hyperbaric oxygenation for cerebral palsy and the brain-injured child (2002), Best Publications, Flagstaff Arizona 109-115
79. Golden Z.L., Neubauer R., Golden C.J., Greene L., Marsh J., and Mleko A. Improvement in cerebral metabolism in chronic brain injury after hyperbaric oxygen therapy. Int J Neurosci 112 (2002) 119-131
80. Singh V.K., Warren R., Averett R., and Ghaziuddin M. Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr Neurol 17 1 (1997) 88-90
81. Singh V.K., and Rivas W.H. Prevalence of serum antibodies to caudate nucleus in autistic children. Neurosci Lett 355 (2004) 53-56
82. Vojdani A., O'Bryan T., Green J.A., et al. Immune response to dietary proteins, gliadin and cerebellar peptides in children with autism. Nutr Neurosci 7 3 (2004) 151-161
83. Singh V.K., Lin S.X., Newell E., and Nelson C. Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in children with autism. J Biomed Sci 9 (2002) 359-364
84. Vojdani A., Campbell A.W., Anyanwu E., Kashanian A., Bock K., and Vojdani E. Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A. J Neuroimmunol 129 (2002) 168-177
85. Vojdani A., Pangborn J.B., Vojdani E., and Cooper E.L. Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major instigators of autoimmunity in autism. Int J Immunopathol Pharmacol 16 3 (2003) 189-199
86. Jyonouchi H., Sun S., and Le H. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol 120 (2001) 170-179
87. + T cells in autism. J Neuroimmunol 85 (1998) 106-109
88. Wakefield A.J., Ashwood P., Limb K., and Anthony A. The significance of ileo-colonic lymphoid nodular hyperplasia in children with autistic spectrum disorder. Eur J Gastroenterol Hepatol 17 (2005) 827-836
89. Ashwood P., Anthony A., Torrente F., and Wakefield A.J. Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J Clin Immunol 24 6 (2004) 664-673
90. Torrente F., Ashwood P., Day R., et al. Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol Psychiatry 7 (2002) 375-382
91. Gupta S. Immunological treatments for autism. J Autism Dev Disord 30 5 (2000) 475-479
92. Zimmerman A.W. Commentary: immunological treatments for autism: in search of reasons for promising approaches. J Autism Dev Disord 30 5 (2000) 481-484
93. Akin M.L., Gulluoglu B.M., Uluutku H., et al. Hyperbaric oxygen improves healing in experimental rat colitis. Undersea Hyperb Med 29 4 (2002) 279-285
94. Luongo C., Imperatore F., Cuzzocrea S., et al. Effects of hyperbaric oxygen exposure on a zymosan-induced shock model. Crit Care Med 26 12 (1998) 1972-1976
95. Sumen G., Cimsit M., and Eroglu L. Hyperbaric oxygen treatment reduces carrageenan-induced acute inflammation in rats. Eur J Pharmacol 431 (2001) 265-268
96. Warren J., Sacksteder M.R., and Thuning C.A. Therapeutic effect of prolonged hyperbaric oxygen in adjuvant arthritis of the rat. Arthritis Rheum 22 4 (1979) 334-339
97. Tokar B., Gundogan A.H., Ilhan H., Bildirici K., Gultepe M., and Elbuken E. The effects of hyperbaric oxygen treatment on the inflammatory changes caused by intraperitoneal meconium. Pediatr Surg Int 19 (2003) 673-676
98. Chen S.Y., Chen Y.C., Wang J.K., et al. Early hyperbaric oxygen therapy attenuates disease severity in lupus-prone autoimmune (NZB X NZW) F1 mice. Clin Immunol 108 (2003) 103-110
99. Buchman A.L., Fife C., Torres C., Smith L., and Aristizibal J. Hyperbaric oxygen therapy for severe ulcerative colitis. J Clin Gastroenterol 33 4 (2001) 337-339
100. James S.J., Cutler P., Melnyk S., et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 80 (2004) 1611-1617
101. Sogut S., Zoroglu S.S., Ozyurt H., et al. Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. Clin Chim Acta 331 (2003) 111-117
102. McGinnis W.R. Oxidative stress in autism. Altern Ther Health Med 10 6 (2004) 22-36
103. Feldmeier J., Carl U., Hartmann K., and Sminia P. Hyperbaric oxygen: does it promote growth or recurrence of malignancy?. Undersea Hyperb Med 30 1 (2003) 1-18
104. Shaw F.L., Handy R.D., Bryson P., Sneyd J.R., and Moody A.J. A single exposure to hyperbaric oxygen does not cause oxidative stress in isolated platelets: no effect on superoxide dismutase, catalase, or cellular ATP. Clin Biochem 38 (2005) 722-726
105. Yatsuzuka H. Effects of hyperbaric oxygen therapy on ischemic brain injury in dogs. Masui 40 2 (1991) 208-223
106. Zamboni W.A., Roth A.C., Russell R.C., Nemiroff P.M., Casas L., and Smoot E.C. The effect of acute hyperbaric oxygen therapy on axial pattern skin flap survival when administered during and after total ischemia. J Reconstr Microsurg 5 4 (1989) 343-347
107. Ozden T.A., Uzun H., Bohloli M., et al. The effects of hyperbaric oxygen treatment on oxidative and antioxidants levels during liver regeneration in rats. Tohoku J Exp Med 203 (2004) 253-265
108. Yasar M., Yildiz S., Mas R., et al. The effect of hyperbaric oxygen treatment on oxidative stress in experimental acute necrotizing pancreatitis. Physiol Res 52 (2003) 111-116
109. Kaelin C.M., Im M.J., Myers R.A., Manson P.N., and Hoopes J.E. The effects of hyperbaric oxygen on free flaps in rats. Arch Surg 125 5 (1990) 607-609
110. Dennog C., Radermacher P., Barnett Y.A., and Speit G. Antioxidant status in humans after exposure to hyperbaric oxygen. Mutat Res 428 (1999) 83-89
111. Yu S.Y., Chiu J.H., Yang S.D., et al. Preconditioned hyperbaric oxygenation protects the liver against ischemia-reperfusion injury in rats. J Surg Res 128 (2005) 28-36
112. Alleva R., Nasole E., Di Donato F., Borghi B., Neuzil J., and Tomasetti M. α-Lipoic acid supplementation inhibits oxidative damage, accelerating chronic wound healing in patients undergoing hyperbaric oxygen therapy. Biochem Biophys Res Commun 333 2 (2005) 404-410
113. Dennog C., Gedik C., Wood S., and Speit G. Analysis of oxidative DNA damage and HPRT mutations in humans after hyperbaric oxygen treatment. Mutat Res 431 (1999) 351-359
114. Benedetti S., Lamorgese A., Piersantelli M., Pagliarani S., Benvenuti F., and Canestrari F. Oxidative stress and antioxidant status in patients undergoing prolonged exposure to hyperbaric oxygen. Clin Biochem 37 (2004) 312-317
115. Chavko M., and Harabin A.L. Regional lipid peroxidation and protein oxidation in rat brain after hyperbaric oxygen exposure. Free Radic Biol Med 20 7 (1996) 973-978
116. Wada K., Miyazawa T., Nomura N., Nawashiro H., and Shima K. Preferential conditions for and possible mechanisms of induction of ischemic tolerance by repeated hyperbaric oxygenation in gerbil hippocampus. Neurosurgery 49 (2001) 160-167
117. Hink J., and Jansen E. Are superoxide and/or hydrogen peroxide responsible for some of the beneficial effects of hyperbaric oxygen therapy?. Med Hypotheses 57 6 (2001) 764-769
118. Barja G. Oxygen radicals, a failure or a success of evolution?. Free Radic Res Commun 18 2 (1993) 63-70
119. McCord J.M. The evolution of free radicals and oxidative stress. Am J Med 108 (2000) 652-659
120. Patel V., Chivukula I.V., Roy S., et al. Oxygen: from the benefits of inducing VEGF expression to managing the risk of hyperbaric stress. Antioxid Redox Signal 7 9-10 (2005) 1377-1387
121. Pablos M.I., Reiter R.J., Chuang J.I., et al. Acutely administered melatonin reduces oxidative damage in lung and brain induced by hyperbaric oxygen. J Appl Physiol 83 (1997) 354-358
122. Pelaia P., Rocco M., De Blasi R.A., et al. Assessment of lipid peroxidation in hyperbaric oxygen therapy: protective role of N-acetylcysteine. Minerva Anestesiol 61 4 (1995) 133-139
123. Hollis A.L., Butcher W.I., Davis H., Henderson R.A., and Stone W.L. Structural alterations in retinal tissues from rats deficient in vitamin E and selenium and treated with hyperbaric oxygen. Exp Eye Res 54 5 (1992) 671-684
124. Boadi W.Y., Thaire L., Kerem D., and Yannai S. Effects of dietary factors on antioxidant enzymes in rats exposed to hyperbaric oxygen. Vet Hum Toxicol 33 2 (1991) 105-109
125. Weber C.A., Duncan C.A., Lyons M.J., and Jenkinson S.G. Depletion of tissue glutathione with diethyl maleate enhances hyperbaric oxygen toxicity. Am J Physiol 258 6 Pt 1 (1990) L308-L312
126. Thom SR, Bhopale VM, Velazquez OC, Goldstein LJ, Thom LH, Buerk DG. Stem cell mobilization by hyperbaric oxygen. Am J Physiol Heart Circ Physiol 2005; in press.
127. Steindler D.A., and Pincus D.W. Stem cells and neuropoiesis in the adult human brain. Lancet 359 (2002) 1047-1054
128. Harch P.G., and Small T. Interview with Dr. Paul Harch: the application of hyperbaric oxygen therapy in chronic neurological conditions. Medical Veritas 2 (2005) 637-646
129. Collet J.P., Vanasse M., Marois P., et al. Hyperbaric oxygen for children with cerebral palsy: a randomised multicentre trial. Lancet 357 (2001) 582-586
130. Marois P., and Vanasse M. Letter to the editor: "Hyperbaric oxygen therapy and cerebral palsy". Dev Med Child Neurol 45 (2003) 646-648
131. Autism Research Institute. Autism Treatment Evaluation Checklist (ATEC) Internet Scoring Program, http://www.autismeval.com/ari-atec/ [accessed 25.01.06].
132. Rellini E., Tortolani D., Trillo S., Carbone S., and Montecchi F. Childhood autism rating scale (CARS) and autism behavior checklist (ABC) correspondence and conflicts with DSM-IV criteria in diagnosis of autism. J Autism Dev Disord 34 6 (2004) 703-708
133. Constantino J.N., Davis S.A., Todd R.D., et al. Validation of a brief quantitative measure of autistic traits: comparison of the social responsiveness scale with the autism diagnostic interview-revised. J Autism Dev Disord 33 4 (2003) 427-433